Donate Now
Home | News | Events | Press | Contact  

About UseNewsletterMessage BoardsAction CenterAdvocateWalk to End Alzheimer’sShopDonate

Find your chapter:

search by state

Alzheimer News 10/28/2009
Text Size controlsNormal font sizeMedium font sizeLarge font size

The Alzheimer’s Association and Eisai Inc. honor Richmond pharmacist for outstanding service to individuals with Alzheimer’s disease

2009 C.A.R.E. (Commitment to Alzheimer’s. Recognition of Excellence.) Pharmacy Award acknowledges excellence in Alzheimer’s disease education and patient care

The Alzheimer’s Association and Eisai Inc. announce today that Heather Greene, PharmD, is the recipient of the 2009 C.A.R.E. Pharmacy Award. 

Dr. Greene is being recognized for the critical role she has played in helping patients and caregivers fight Alzheimer’s disease. As a Geriatric Consultant Pharmacist with the Riverside Health System at the Richmond PACE (Program of All-inclusive Care for the Elderly) facility, she is a member of an interdisciplinary team that provides care for some of the areas frailest seniors.  In the nomination for her work with Alzheimer’s disease patients and caregivers, Dr. Greene was described as someone “who goes far beyond being a pharmacist when she works with patients and their families…a caring person, a knowledgeable pharmacist, an excellent trainer and educator and a dedicated volunteer.” She received her Doctor of Pharmacy degree from the School of Pharmacy at Virginia Commonwealth University in Richmond, VA. 

The C.A.R.E. Pharmacy Award recognizes the extraordinary impact that pharmacists can have on the lives of individuals with Alzheimer’s disease and their families. Now in its ninth year, the award is a reflection of Eisai’s human health care (hhc) mission, which is to give first thought to patients and their families, and to increasing the benefits that health care provides.

“As a member of the C.A.R.E. Pharmacy Award selection committee, I saw the impressive contributions of nominated pharmacists who work as a part of a cohesive team of care providers for people with Alzheimer’s disease,” said Elizabeth Gould, MSW, LCSW, director of quality care programs for the Alzheimer’s Association. “We applaud this year’s winner on her extraordinary efforts in building a relationship with those living with Alzheimer’s and their caregivers, helping to educate them about Alzheimer’s disease and enhancing the support they receive.”

A $1,500 donation will be made to the Greater Richmond Alzheimer’s Association Chapter, which serves the area where the award recipient resides, and also to the Massachusetts/New Hampshire and Greater Illinois Alzheimer’s Association Chapters in recognition of having the most award nominations submitted from within their service areas.

“Alzheimer’s is a devastating disease for individuals as well as for their caregivers and family members,” said Cynthia Schwalm, President, U.S. Pharmaceuticals, Eisai Inc. “Eisai recognizes the integral role pharmacists play in each patient’s treatment and care, through ongoing monitoring, counseling and support. We are proud to honor this year’s C.A.R.E. award recipient for her invaluable contributions to enhance the quality of care for people affected by Alzheimer’s disease.”

About the Alzheimer’s Association

The Alzheimer’s Association is the leading voluntary health organization in Alzheimer’s research, care and support. Our mission is to eliminate Alzheimer’s disease through the advancement of research, provide and enhance care and support for all affected, and reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. For more information, visit http://www.alz.org/.

About Eisai Inc.

Eisai Inc. is a wholly-owned subsidiary of Eisai Corporation of North America.  Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), the company began marketing its first product in the United States in 1997 and has rapidly grown to become a fully integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion.  Eisai Inc.’s areas of commercial focus include neurology, gastrointestinal disorders and oncology/critical care.  The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world.  Headquartered in Woodcliff Lake, New Jersey, Eisai Inc. has several R&D facilities in Massachusetts, New Jersey and North Carolina, as well as manufacturing facilities in Maryland and North Carolina.  For more information about Eisai, please visit http://www.eisai.com/.


 


 

Alzheimer's Association

Our vision is a world without Alzheimer's
Formed in 1980, the Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research.